ArticleERJ open research2025

AeroVax: study protocol for a randomised, double-blind, placebo-controlled, phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans.

Adam S Komorowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.